Ophthalmology

This online, on-demand virtual symposium brings together renowned experts in Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available and investigational therapies. This educational activity is an archive...

This online, on-demand virtual symposium brings together renowned experts in neurotrophic keratitis (NK). In this educational program, these experts discuss the symptoms associated with NK, present video demonstrations of various techniques for corneal sensitivity testing, and share their perspectives and...

Review of data presented at recent conferences on newer therapies for neovascular age-related macular degeneration and diabetic macular edema. This online activity is designed to update clinicians on data presented at meetings of retina specialists; these include the Retina World...

Designed for today’s eye care professionals, EyeCon delivers practical strategies you can apply immediately in practice. Explore the latest advances in diagnostic technologies, emerging therapies, and clinical trial data shaping the future of eye care.

This online activity is designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025. Expert thought leaders provide insights to help...

X-linked retinitis pigmentosa (XLRP), which commonly results from mutations in the RPGR gene or the RP2 gene, is frequently more severe than other forms of retinitis pigmentosa. The onset of legal blindness occurs decades earlier in male patients than in...

Vascular endothelial growth factor (VEGF) is essential in the pathogenesis of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). As such, VEGF inhibitors have become commonly used and effective pharmacologic strategies for both diseases. However, limitations exist, such...

In this program, a panel of retina specialists share their insights into the use of newer anti-VEGF agents, which offer the opportunity for extended treatment intervals for the treatment of retinal vein occlusion (RVO), neovascular age-related macular degeneration, and diabetic...

Macular telangiectasia type 2 (MacTel) is a rare, progressive retinal disease characterized by neurodegenerative changes, localized retinal degeneration, and alterations in the retinal vasculature. It usually presents bilaterally and leads to gradual central vision loss, and its early signs and...

Release Date: October 15, 2025 Expiration Date: October 15, 2026 Activity Overview This online, on-demand virtual symposium brings together renowned experts in neovascular retinal diseases including AMD, DME and RVO. In this educational program, these experts use a case-based format...